@xconomy.com 3 months ago
VenBio Partners Bags $394M to Back More Medicine-Making Biotechs
@xconomy.com 5 months ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com 6 months ago
Pfizer Taps Insilico Medicine to Use AI for Drug Target Discovery
@xconomy.com 8 months ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com 9 months ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com 10 months ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@venturebeat.com 10 months ago
Pfizer launches pilot with home robot Mabu to study patient response to AI
@xconomy.com 10 months ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com 10 months ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@techcrunch.com 10 months ago
All that glitters is not gold: How healthtech startups can achieve true value
@xconomy.com 11 months ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com 1 year ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com 1 year ago
With Data, Pfizer/Sangamo Step Forward in Hemophilia Gene Therapy Race
@xconomy.com 1 year ago
PanTheryx Lands $50M to Use “First Milk” to Target Gut Microbiome
@xconomy.com 1 year ago
Oncolytics Bio Tacks On Cancer Combo Study with Merck KGaA, Pfizer
@xconomy.com 1 year ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@techcrunch.com 1 year ago
Drone delivery startup Zipline launches UAV medical program in Ghana
@xconomy.com 1 year ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com 1 year ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com 1 year ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com 1 year ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com 1 year ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com 1 year ago
Former Zavante Executive Tapped as Abide Therapeutics President
@xconomy.com 1 year ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
@xconomy.com 1 year ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More
@xconomy.com 1 year ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com 1 year ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com 1 year ago
ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front
@xconomy.com 1 year ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com 1 year ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com 1 year ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug
@venturebeat.com 2 years ago
AI could help reduce the administrative costs of health care
@SeverineLienard 3 years ago
[#AI] #IBMWatson & Pfizer join forces on cancer drug discovery http://buff.ly/2g78CV3 #BigData #Health… https://twitter.com/i/web/status/805647928715079681
@KirkDBorne 3 years ago
How @Pfizer uses #PredictiveModeling and #BigData science to predict clinical trial risks: https://lnkd.in/e6q99TR #DataScience
@techcrunch.com 4 years ago
IBM, Pfizer launch joint experiment to help measure Parkinson’s symptoms using IoT and analytics